Overview

Subvenite is approved by the U.S. Food and Drug Administration (FDA) as both an adjunctive (add-on) and monotherapy (standalone) treatment for epilepsy. As adjunctive therapy, it is approved for people aged 2 years and older with partial-onset seizures, primary generalized tonic-clonic (PGTC) seizures, and seizures associated with Lennox-Gastaut syndrome. As monotherapy, it is approved for people aged 16 and older who are switching from another single antiepileptic drug such as carbamazepine, phenytoin, phenobarbital, primidone, or valproate. Subvenite is also known by its drug name, lamotrigine.

Subvenite is an antiepileptic drug. Scientists believe it works by reducing abnormal electrical activity in the brain, which helps to prevent or decrease the frequency of seizures.

How do I take it?

Prescribing information states that Subvenite is taken by mouth as an oral suspension. The dosing schedule depends on the person’s age, the type of seizure being treated, and whether other antiepileptic medications are being used. To reduce the risk of serious side effects, the dosage must be increased gradually. Subvenite should be taken exactly as prescribed by a healthcare provider.

Side effects

Common side effects of Subvenite include dizziness, headache, double vision (diplopia), problems with coordination (ataxia), nausea, blurred vision, and drowsiness (somnolence). In children, common side effects also include vomiting, infection, fever, accidental injury, diarrhea, abdominal pain, and tremor.

Rare but serious side effects may include life-threatening skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis, severe allergic reactions (including drug reaction with eosinophilia and systemic symptoms or DRESS), hemophagocytic lymphohistiocytosis) (inflammation throughout the body), serious heart rhythm problems, blood disorders (such as neutropenia, thrombocytopenia, or pancytopenia), suicidal thoughts or behaviors, aseptic meningitis (inflammation of the brain lining without infection), and severe medication errors due to confusion with other drug names.

For more information about this treatment, visit:
Subvenite (Lamotrigine) Oral Suspension — OWP Pharmaceuticals